Jordi Rello, MD, PhD
Vall d'Hebron University Hospital, CIBERES, VHIR, Universitat Autonoma de Barcelona, Spain
Jordi Rello is Professor of Medicine at the Universitat Autònoma de Barcelona. Medical Degree with Honors for Universitat de Barcelona in 1985, he earned in 1990 his Degree of Doctor of Medicine with Honors with a translational doctoral thesis on catheter-related infections and did the PhD programme on Infectious Diseases at the University of Barcelona, followed by a residence and fellowship in Pulmonary and Critical Care at the Hospital de Sant Pau in Barcelona, Spain. He directed 15 doctoral thesis.
Director of the Clinical Research & Innovation in Pneumonia and Sepsis (CRIPS) Group at Vall d'Hebron Research Institute. He developed clinical practice in infections in the critically ill patient from 1990, currently in Hospital Vall d’Hebron with a large proportion of lung trasplant and BMT recipients.
He had training in business management and leaded a clinical department over 15 years in two University Hospitals. He did a short stay in Harvard Medical school for training in epidemiology of nosocomial infections. He’s a well communicator, being trained in media interviews.
He has received numerous honors and awards, being co-recipient of the Emmanuel Wolinski Award by the IDSA. Past secretary of the Catalonian Society of Infectious Diseases, he has been very active in the ESCMID, funding the Critically Ill Patient Study Group (ESGCIP), organizing PG courses and currently co-chairing a Position Paper and Clinical Practice Guidelines.
Advisor for WHO and Spanish Health Ministry and Executive Member of ISARIC during pandemic influenza, he coordinated the steering committee of the ESCMID Registry, where served as Deputy and Chair of the Infection Section in the past decade.
His areas of research include studies on prevention and control of hospital-acquired infections, epidemiology of ventilator-associated pneumonia or severe community-acquired pneumonia, and treatment of infections & sepsis in critically ill patients. He was active in developing many educational strategies, member of the panel that developed the Deescalation ™ and the APEX projects or the Academy of Infection Management. He conducted many phase II-III RCT on new antimicrobial agents and monoclonal antibodies for sepsis. Prof Rello has large experience in Ad Boards for drug development and organizing educational preceptorship programs. An International Course on Antimicrobial Strategies In Sepsis (ICASIS) is organized each April, in Barcelona.Professor Rello is co-author of above 400 indexed articles on infections, mostly within the 1Q. He served as reviewer for above 25 journals and served in the Advisory Board of many Journals, enclosing Enfermedades Infecciosas and Clinical Microbiologia, Sepsis, Medicina Intensiva, Intensive Care Medicine. He has edited many international Books and Book Series, beig co-editor of the “Critical Care Infectious Diseases Textbook” (two editions) and the “Perspectives in Critical Care Infectious Infectious Diseases”.